High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the response to treatment and side effects associated
with high dose irinotecan in patients with recurrent brain tumors.